{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:31:06Z","timestamp":1760149866182,"version":"build-2065373602"},"reference-count":54,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:00:00Z","timestamp":1694995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology International"],"abstract":"<jats:p>Immune thrombocytopenia (ITP) is an autoimmune blood disorder characterised by isolated severe thrombocytopenia. Arterial thrombotic events, such as acute ischaemic stroke (AIS), are rare complications. A 56-year-old woman with chronic ITP on eltrombopag and dexamethasone therapy presented to the emergency department due to AIS in the vertebrobasilar territory, and lower abdominal pain. The computed tomography (CT) scan of the head was unremarkable, whereas CT angiography revealed left vertebral artery occlusion. As the platelet count was sufficient, intravenous thrombolysis (IVT) was initiated. However, after 15 min, an anaphylactic reaction occurred, which was appropriately solved. Although the IVT was prematurely stopped, the NIHSS score improved from 7 to 2, and the follow-up head CT scan remained unremarkable. CT angiography of the thoracoabdominal aorta revealed multiple thrombi in the infrarenal aorta, inferior mesenteric artery (IMA), and left renal artery. The abdominal pain subsided after IVT, but recurred within 24 h. Repeated CT angiography showed ischaemia of the descending colon, with persistent IMA occlusion. After the hemicolectomy condition stabilised. Discrete left-sided ataxia and impaired sensation were the only neurological sequelae. We found two articles reporting only three patients with ITP who suffered AIS and were treated with IVT. A favourable outcome was observed in two cases, while one patient suffered an intracranial haemorrhage (ICH) and died. A review of AIS cases with undefined thrombocytopenia treated with IVT reported ICH in up to 6.8% of patients. Our case suggests that IVT for AIS may be effective in patients with ITP. Further data are needed to better clarify this issue.<\/jats:p>","DOI":"10.3390\/neurolint15030074","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T03:02:17Z","timestamp":1695092537000},"page":"1191-1199","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Treatment of Acute Ischaemic Stroke and Concomitant Multiple Arterial Splanchnic Thromboses in a Patient with Immune Thrombocytopenia on Thrombopoietin Agonist: A Case Report"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9494-160X","authenticated-orcid":false,"given":"Senta","family":"Frol","sequence":"first","affiliation":[{"name":"Department of Vascular Neurology, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia"},{"name":"Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janja","family":"Pretnar Oblak","sequence":"additional","affiliation":[{"name":"Department of Vascular Neurology, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia"},{"name":"Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi\u0161o","family":"\u0160abovi\u010d","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia"},{"name":"Department of Vascular Disorders, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5933-0985","authenticated-orcid":false,"given":"Pawel","family":"Kermer","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nordwest-Krankenhaus Sanderbusch, Friesland Kliniken GmbH, 26452 Sande, Germany"},{"name":"Department of Neurology, University of G\u00f6ttingen, Robert-Koch Str. 40, 37075 G\u00f6ttingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matja\u017e","family":"Sever","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia"},{"name":"Department of Haematology, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1017\/cjn.2020.138","article-title":"The Clinical Conundrum of Managing Ischemic Stroke in Patients with Immune Thrombocytopenia","volume":"48","author":"Alrohimi","year":"2021","journal-title":"Can. J. Neurol. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1182\/blood-2014-05-578336","article-title":"Epidemiology of incident immune thrombocytopenia: A nationwide population-based study in France","volume":"124","author":"Moulis","year":"2014","journal-title":"Blood"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"103820","DOI":"10.1016\/j.ebiom.2022.103820","article-title":"Recent advances in the mechanisms and treatment of immune thrombocytopenia","volume":"76","author":"Provan","year":"2022","journal-title":"eBioMedicine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2141.2010.08234.x","article-title":"Thromboembolic events are not uncommon in 319 patients with immune thrombocytopenia","volume":"150","author":"Thachil","year":"2010","journal-title":"Br. J. Haematol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11239-009-0431-2","article-title":"Recurrent ischemic stroke in a patient with idiopathic thrombocytopenic purpura","volume":"30","author":"Rhee","year":"2010","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","article-title":"2018 Guidelines for the Early Management of Patients with Acute Ischemic Stroke: A 349 Guideline for Healthcare Professionals from the American Heart Association\/American 350 Stroke Association","volume":"49","author":"Powers","year":"2018","journal-title":"Stroke"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"I","DOI":"10.1177\/2396987321989865","article-title":"European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke","volume":"6","author":"Berge","year":"2021","journal-title":"Eur. Stroke J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.07.017","article-title":"Immune-Thrombotic Thrombocytopenic Purpura is a Rare Cause of Ischemic Stroke in Young Adults: Case Reports and Literature Review","volume":"27","author":"Tomich","year":"2018","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/1076029614545213","article-title":"A Seeming Paradox: Ischemic Stroke in the Context of Idiopathic Thrombocytopenic Purpura","volume":"22","author":"Mihalov","year":"2016","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/jth.13940","article-title":"The association between idiopathic thrombocytopenic purpura and cardiovascular disease: A retrospective cohort study","volume":"16","author":"Chandan","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"ref_12","first-page":"3184346","article-title":"Vertebral Artery Thrombosis in Chronic Idiopathic Thrombocytopenic Purpura","volume":"2017","author":"Hindi","year":"2017","journal-title":"Case Rep. Hematol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00381-015-2619-4","article-title":"Ischemic stroke in pediatric moyamoya disease associated with immune thrombocytopenia\u2014A case report","volume":"31","author":"Hayashi","year":"2015","journal-title":"Childs Nerv. Syst."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.04.032","article-title":"Elevated platelet microparticle levels after acute ischemic stroke with concurrent idiopathic thrombocytopenic purpura","volume":"23","author":"Ichijo","year":"2014","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jstrokecerebrovasdis.2008.01.014","article-title":"A patient with idiopathic thrombocytopenic purpura presenting with an acute ischemic stroke","volume":"17","author":"Theeler","year":"2008","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s10072-020-04746-2","article-title":"Ischemic stroke\/transient ischemic attack in adults with primary immune thrombocytopenia: A meta-analysis","volume":"42","author":"Pan","year":"2021","journal-title":"Neurol. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s10072-014-1843-0","article-title":"Ischemic stroke associated with immune thrombocytopenia: Lesion patterns and characteristics","volume":"35","author":"Park","year":"2014","journal-title":"Neurol. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/1076029611425380","article-title":"Ischemic stroke in the setting of chronic immune thrombocytopenia in an elderly patient\u2014A therapeutic dilemma","volume":"18","author":"Fareed","year":"2012","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"106693","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106693","article-title":"Risk factors and characteristics of ischemic stroke in patients with immune thrombocytopenia: A retrospective cohort study","volume":"31","author":"Rong","year":"2022","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13256-018-1955-x","article-title":"A serious thrombotic event in a patient with immune thrombocytopenia requiring intravenous immunoglobulin: A case report","volume":"13","author":"Rungjirajittranon","year":"2019","journal-title":"J. Med. Case Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e0332","DOI":"10.1097\/MD.0000000000010332","article-title":"Bilateral visual loss and cerebral infarction after spleen embolization in a trauma patient with idiopathic thrombocytopenic purpura: A case report","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11239-014-1146-6","article-title":"Ischemic stroke associated with immune thrombocytopenia","volume":"40","author":"Zhao","year":"2015","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/ejh.12181","article-title":"Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: A pooled analysis of 13 clinical trials","volume":"91","author":"Rodeghiero","year":"2013","journal-title":"Eur. J. Haematol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"103581","DOI":"10.1016\/j.critrevonc.2022.103581","article-title":"Risk of thrombosis with thrombopoietin receptor agonists for ITP patients: A systematic review and meta-analysis","volume":"171","author":"Tjepkema","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3324\/haematol.2016.161968","article-title":"Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia","volume":"102","author":"Cines","year":"2017","journal-title":"Haematologica"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/blood.2021010735","article-title":"Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia","volume":"138","author":"Palandri","year":"2021","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/j.1538-7836.2010.03830.x","article-title":"Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP)","volume":"8","author":"Gernsheimer","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1182\/blood-2017-04-748707","article-title":"Safety and efficacy of long-term treatment of chronic\/persistent ITP with eltrombopag: Final results of the EXTEND study","volume":"130","author":"Wong","year":"2017","journal-title":"Blood"},{"key":"ref_29","first-page":"240","article-title":"Real-world experience of eltrombopag in immune thrombocytopenia","volume":"10","author":"Mishra","year":"2020","journal-title":"Am. J. Blood Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ajh.23249","article-title":"Atypical thrombotic thrombocytopenic purpura in a middle-aged woman who presented with a recurrent stroke","volume":"88","author":"Idowu","year":"2013","journal-title":"Am. J. Hematol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/jca.20276","article-title":"Stroke in a young patient treated by alteplase heralding an acquired thrombotic thrombocytopenic purpura","volume":"26","author":"Sevy","year":"2011","journal-title":"J. Clin. Apher."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1034\/j.1600-0609.2003.00026.x","article-title":"Rituximab induces remission of cerebral ischemia caused by thrombotic thrombocytopenic purpura","volume":"70","author":"Tsai","year":"2003","journal-title":"Eur. J. Haematol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e690","DOI":"10.1212\/WNL.0000000000004982","article-title":"Thrombolysis in Stroke Patients (TRISP) Collaborators. Intravenous thrombolysis and platelet count","volume":"90","author":"Gensicke","year":"2018","journal-title":"Neurology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","article-title":"Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: A meta-analysis of individual patient data from randomised trials","volume":"384","author":"Emberson","year":"2014","journal-title":"Lancet"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1474-4422(16)30076-X","article-title":"Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: A secondary analysis of an individual patient data meta-analysis","volume":"15","author":"Whiteley","year":"2016","journal-title":"Lancet Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1161\/STROKEAHA.119.026861","article-title":"Association between intravenous thrombolysis and anaphylaxis among medicare benefeciaries with acute ischemic stroke","volume":"50","author":"Lerario","year":"2019","journal-title":"Stroke"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/all.12193","article-title":"About the role and underlying mechanisms of cofactors in anaphylaxis","volume":"68","author":"Fischer","year":"2013","journal-title":"Allergy"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/pr.2015.6","article-title":"Association of primary immune thrombocytopenia and common allergic diseases among children","volume":"77","author":"Chiang","year":"2015","journal-title":"Pediatr. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"11717","DOI":"10.1038\/s41598-020-68647-2","article-title":"Relationship of primary immune thrombocytopenic purpura and atopia among children: A case control study","volume":"10","author":"Bahoush","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.thromres.2021.02.021","article-title":"Massive intrasplenic arterial thrombosis in a patient with chronic ITP during the development of an Evans syndrome","volume":"208","author":"Colomo","year":"2021","journal-title":"Thromb. Res."},{"key":"ref_41","first-page":"e17478","article-title":"Severe Portal Vein Thrombosis During Eltrombopag Treatment Concomitant Splenectomy for Immune Thrombocytopenia","volume":"13","author":"Saito","year":"2021","journal-title":"Cureus"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1177\/09612033211065140","article-title":"Catastrophic anti-phospholipid syndrome with Libman-Sacks endocarditis following eltrombopag therapy for immune thrombocytopenic purpura: A case report","volume":"30","author":"Dichtwald","year":"2021","journal-title":"Lupus"},{"key":"ref_43","first-page":"e33615","article-title":"Risk of Thromboembolism with Eltrombopag: A Case Report of Deep Vein Thrombosis and Bilateral Pulmonary Embolism","volume":"15","author":"Ghumman","year":"2023","journal-title":"Cureus"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3109\/09537104.2012.758359","article-title":"Extensive cerebral venous sinus thrombosis following a dose increase in eltrombopag in a patient with idiopathic thrombocytopenic purpura","volume":"25","author":"Mulla","year":"2014","journal-title":"Platelets"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2174\/1574886311207040255","article-title":"Eltrombopag Induced Thrombosis: A Case with Acute Myocardial Infarction","volume":"11","author":"Gunes","year":"2016","journal-title":"Curr. Drug Saf."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1111\/1346-8138.15171","article-title":"Cutaneous thrombosis associated with eltrombopag treatment for immune thrombocytopenia","volume":"47","author":"Iinuma","year":"2020","journal-title":"J. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1159\/000507987","article-title":"Eltrombopag Use for Treatment of Thrombocytopenia in a Patient with Chronic Liver Disease and Portal Vein Thrombosis: Case Report","volume":"13","author":"Mohamed","year":"2020","journal-title":"Case Rep. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Oo, Z., Manvar, K., and Wang, J.C. (2022). Eltrombopag-Induced Thrombocytosis and Thrombosis in Patients With Antiphospholipid Syndrome and Immune Thrombocytopenic Purpura. J. Investig. Med. High Impact Case Rep., 10.","DOI":"10.1177\/23247096211060581"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12959-022-00407-w","article-title":"Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia","volume":"20","author":"Bosi","year":"2022","journal-title":"Thromb. J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3960\/jslrt.53.151","article-title":"Portal vein thrombosis during eltrombopag treatment for immune thrombocytopenic purpura in a patient with liver cirrhosis due to hepatitis C viral infection","volume":"53","author":"Kawano","year":"2013","journal-title":"J. Clin. Exp. Hematop."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"121","DOI":"10.14309\/crj.2016.20","article-title":"Severe Thrombotic Complication of Eltrombopag in a Cirrhotic Patient","volume":"3","author":"Baumann","year":"2016","journal-title":"ACG Case Rep. J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/ejh.13929","article-title":"Platelet kinetics in patients with chronic immune thrombocytopaenia treated with thrombopoietin receptor agonists","volume":"110","author":"Pravdic","year":"2023","journal-title":"Eur. J. Haematol."},{"key":"ref_53","first-page":"1020","article-title":"Evaluation of the procoagulant state in chronic immune thrombocytopenia before and after eltrombopag treatment-a prospective cohort study","volume":"21","author":"Poolen","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1080\/09537104.2019.1639655","article-title":"Increased microvesicle-associated thrombin generation in patients with immune thrombocytopenia after initiation of thrombopoietin receptor agonists","volume":"31","author":"Garabet","year":"2020","journal-title":"Platelets"}],"container-title":["Neurology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2035-8377\/15\/3\/74\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:52:57Z","timestamp":1760129577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2035-8377\/15\/3\/74"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,18]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["neurolint15030074"],"URL":"https:\/\/doi.org\/10.3390\/neurolint15030074","relation":{},"ISSN":["2035-8377"],"issn-type":[{"type":"electronic","value":"2035-8377"}],"subject":[],"published":{"date-parts":[[2023,9,18]]}}}